Web Date: January 26, 2009
FDA Clears Stem Cell Clinical Trial
The Food & Drug Administration has given Geron, a small California-based biotech company, the green light to inject living cells manufactured from human embryonic stem cells into a handful of patients with spinal cord injuries.
The trials, set to begin this summer, will be the first in the world to test the safety of a therapy derived from human embryonic stem cells in people.
A lot of . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society